Amanote Research
Register
Sign In
Renal Damage During Treatment With Antirheumatic Drugs.
BMJ
doi 10.1136/bmj.2.6138.664
Full Text
Open PDF
Abstract
Available in
full text
Date
September 2, 1978
Authors
P A Dieppe
D V Doyle
H C Burry
Publisher
BMJ
Related search
Quality of Life of Patients With Advanced/Metastatic Renal Cell Carcinoma During the Treatment Period With Targeted Drugs
Üroonkoloji Bülteni
Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs
Arthritis Care and Research
Rheumatology
Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs
Reumatologia
Rheumatology
Allergy
Immunology
Kinase Inhibitors: A New Class of Antirheumatic Drugs
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Persistence With Biological Disease-Modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
Drugs - Real World Outcomes
Pharmacology
Clinical Trial of the Therapeutic Value of Certain Antirheumatic Drugs
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis
Arthritis Care and Research
Rheumatology
Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983-2009
Arthritis Care and Research
Rheumatology
OP0057 Fluorescence Optical Imaging in Juvenile Idiopathic Polyarticular Disease Before and During Antirheumatic Treatment